4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.99 +0.53 (+4.25%)
At close: Nov 11, 2026 · 4:00 PM EST

4D Molecular Therapeutics (FDMT) Gains from Sales and Divestitures (2020 - 2026)

Updated

4D Molecular Therapeutics (FDMT) posted Gains from Sales and Divestitures of -$2,000 for Q1 2021.

Analysis

4D Molecular Therapeutics (FDMT) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends

For FY2020, 4D Molecular Therapeutics' Gains from Sales and Divestitures came in at $1,000.

  • In prior years, 4D Molecular Therapeutics' Gains from Sales and Divestitures was -$7,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 4D Molecular Therapeutics 875.59 Mn -584.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -54,000.00
Mar 31, 2026 11,000.00
Jun 30, 2025 631,000.00
Mar 31, 2025 -631,000.00
Mar 31, 2021 -2,000.00
Dec 31, 2020 1,000.00
API Access

4D Molecular Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=FDMT&period=max&api_key=YOUR_API_KEY